Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cosimo Cianfarini

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Transplantation|February 16, 2024
Delayed Graft Function and the Renin-angiotensin SystemFatmah Yamani, Cosimo Cianfarini, Daniel Batlle
American Journal of Physiology. Renal Physiology|July 4, 2024
Altered kidney distribution and loss of ACE2 into the urine in acute kidney injuryMina Shirazi, Cosimo Cianfarini, Ahmed Ismail, et al.
Cells|February 9, 2024
Soluble Angiotensin-Converting Enzyme 2 Protein Improves Survival and Lowers Viral Titers in Lethal Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection with the Delta VariantCosimo Cianfarini, Luise Hassler, Jan Wysocki, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2022
Superiority of intranasal over systemic administration of bioengineered soluble ACE2 for survival and brain protection against SARS-CoV-2 infectionLuise Hassler, Jan Wysocki, Jared T Ahrendsen, et al.
Life Science Alliance|April 11, 2023
Intranasal soluble ACE2 improves survival and prevents brain SARS-CoV-2 infectionLuise Hassler, Jan Wysocki, Jared T Ahrendsen, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Transplantation|February 16, 2024
Delayed Graft Function and the Renin-angiotensin SystemFatmah Yamani, Cosimo Cianfarini, Daniel Batlle
American Journal of Physiology. Renal Physiology|July 4, 2024
Altered kidney distribution and loss of ACE2 into the urine in acute kidney injuryMina Shirazi, Cosimo Cianfarini, Ahmed Ismail, et al.
Cells|February 9, 2024
Soluble Angiotensin-Converting Enzyme 2 Protein Improves Survival and Lowers Viral Titers in Lethal Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection with the Delta VariantCosimo Cianfarini, Luise Hassler, Jan Wysocki, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2022
Superiority of intranasal over systemic administration of bioengineered soluble ACE2 for survival and brain protection against SARS-CoV-2 infectionLuise Hassler, Jan Wysocki, Jared T Ahrendsen, et al.
Life Science Alliance|April 11, 2023
Intranasal soluble ACE2 improves survival and prevents brain SARS-CoV-2 infectionLuise Hassler, Jan Wysocki, Jared T Ahrendsen, et al.
Pageof 1